Clínica Universitaria de Navarra -ko ikertzaileekin lankidetzan egindako argitalpenak (23)

2024

  1. Re-irradiation for progressive Diffuse Intrinsic Pontine Glioma (DIPG): The Spanish experience

    EJC Paediatric Oncology, Vol. 4

2023

  1. Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document

    Revista Espanola de Cardiologia, Vol. 76, Núm. 3, pp. 183-196

  2. Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document

    Radiologia, Vol. 65, Núm. 3, pp. 269-284

2022

  1. Reply to Leonard P. Bokhorst and Berdine L. Heesterman's Words of Wisdom re: High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Localised Prostate Cancer (DART 01/05): 10-Year Results of a Phase 3 Randomised, Controlled Trial. Eur Urol. 2022;82:441

    European Urology

2020

  1. Adaptation and validation of the ICU Mobility Scale in Spain

    Enfermeria Intensiva, Vol. 31, Núm. 3, pp. 131-146

2019

  1. Assessment of ion recombination correction and polarity effects for specific ionization chambers in flattening-filter-free photon beams

    Physica Medica, Vol. 67, pp. 176-184

  2. Degree of implementation of preventive strategies for post-ICU syndrome: Multi-centre, observational study in Spain

    Enfermeria Intensiva, Vol. 30, Núm. 2, pp. 59-71

2018

  1. Amyloid PET in neurodegenerative diseases with dementia

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 6, pp. 397-406

2017

  1. 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 44, Núm. 9, pp. 1575-1587

2014

  1. Medicina nuclear en España: Alta tecnología 2013

    Revista Espanola de Medicina Nuclear e Imagen Molecular

2012

  1. Comparison of limited-volume perioperative high-dose-rate brachytherapy and wide-field external irradiation in resected head and neck cancer

    Head and Neck, Vol. 34, Núm. 8, pp. 1081-1088

  2. External-beam radiation therapy and high-dose rate brachytherapy combined with long-term androgen deprivation therapy in high and very high prostate cancer: Preliminary data on clinical outcome

    International Journal of Radiation Oncology Biology Physics, Vol. 82, Núm. 3

  3. Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: A validation phase II trial

    International Journal of Radiation Oncology Biology Physics, Vol. 83, Núm. 2, pp. 587-593

  4. Long-term results of 1-week intravaginal high-dose-rate brachytherapy alone for endometrial cancer

    Brachytherapy, Vol. 11, Núm. 2, pp. 119-124

2011

  1. Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB)

    International Journal of Radiation Oncology Biology Physics, Vol. 81, Núm. 4

  2. Determinants of toxicity, patterns of failure, and outcome among adult patients with soft tissue sarcomas of the extremity and superficial trunk treated with greater than conventional doses of perioperative high-dose-rate brachytherapy and external beam radiotherapy

    International Journal of Radiation Oncology Biology Physics, Vol. 81, Núm. 4

  3. Interaction of 2-Gy equivalent dose and margin status in perioperative high-dose-rate brachytherapy

    International Journal of Radiation Oncology Biology Physics, Vol. 79, Núm. 4, pp. 1158-1163

2010

  1. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer

    International Journal of Gynecological Cancer, Vol. 20, Núm. 1, pp. 133-140

2008

  1. Comparison of gated SPECT with other imaging techniques used in cardiology

    Revista Espanola de Cardiologia Suplementos, Vol. 8, Núm. B

2006

  1. Tegafur and 5-fluorouracil pelvic tissue concentrations in rectal cancer patients receiving preoperative chemoradiation

    Clinical and Translational Oncology, Vol. 8, Núm. 7, pp. 500-507